Búsqueda | BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas

1.

Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983-1987). European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group.

Nitti, D; Wils, J; Sahmoud, T; Curran, D; Couvreur, M L; Lise, M; Rauschecker, H; dos Santos, J G; Stremmel, W; Roelofsen, F.

Eur J Cancer ; 33(8): 1209-15, 1997 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-9301444

2.

Interferon-alpha does not improve the antineoplastic efficacy of high-dose infusional 5-fluorouracil plus folinic acid in advanced colorectal cancer. First results of a randomized multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO).

Köhne, C H; Wilke, H; Hecker, H; Schöffski, P; Käufer, C; Rauschecker, H; Andreesen, R; Ohl, U; Lange, H J; Klaassen, U.

Ann Oncol ; 6(5): 461-6, 1995 May.

Artículo en Inglés | MEDLINE | ID: mdl-7669711

3.

Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial. European Organisation for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group, the Gruppo Interdisciplinare Valutazione Interventi in Oncologia, and the Japanese Foundation for Cancer Research.

Rougier, P; Sahmoud, T; Nitti, D; Curran, D; Doci, R; De Waele, B; Nakajima, T; Rauschecker, H; Labianca, R; Pector, J C; Marsoni, S; Apolone, G; Lasser, P; Couvreur, M L; Wils, J.

Lancet ; 351(9117): 1677-81, 1998 Jun 06.

Artículo en Inglés | MEDLINE | ID: mdl-9734883

BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas - MTCI

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983-1987). European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group.

Interferon-alpha does not improve the antineoplastic efficacy of high-dose infusional 5-fluorouracil plus folinic acid in advanced colorectal cancer. First results of a randomized multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO).